Dot Emarat – A diet that helps get rid of cancer quickly

The journal Nature has confirmed that a dietary ketone diet improves the functioning of the brain and muscles and increases the effectiveness of anticancer drugs in the rapid elimination of tumors.

An article from a team of researchers at the Mayer Cancer Center in New York, led by Benjamin Hopkins, This effective effect of the ketone diet on the results of chemotherapy makes us think about how certain therapeutic traditions, including including glucose, eating high-sugar foods or glucocorticoids help the survival of cancer patients. "

The" ketone diet "Today among fitness enthusiasts and

This system is distinguished from other food systems where the main source of calories is not carbohydrates but fats and vitamins. proteins

This dietary change forces the brain and other organs not to use glucose, but fatty acids and ketones.A major source of energy

This system forces the muscles and cells of the body. brain to switch to a special energy saving system, making the muscles more resilient and the brain more resistant to aging.

For this reason, the "ketone diet" Today between cyclists and runners in the

Hopkins and his colleagues found an unexpected new use of this diet during their study of the behavior of cancer cells generated by one of the most common mutations, namely, the mages in the PI3KCA gene

This section of the DNA

Scientists have recently discovered that the level of activity of PIK3CA is related to the amount of insulin and glucose present in the cell: the higher the amount of hormone, the higher the amount of hormone is high, the gene is more active The scientists concluded that the inhibition and blocking of the work of this gene and of its proteins can make cancer cells more sensitive to chemotherapy.

However, the effect of PI3KCA inhibitory substances was only temporary for a few hours. (19659002) .This problem was overcome by the use of the ketone diet with Gliflozin, which eliminated all the negative side effects that accompanied the PI3KCA inhibitor.

In the near future, Benjamin Hopkins and his team will test a number of patients to join the efficacy and safety of this method in the control of tumors and cancer in humans.

Source: Novosti